Table 3 Univariable and multivariable analysis of baseline characteristics associated with overall survival.
Univariable analysis | Multivariable analysis | ||||||
---|---|---|---|---|---|---|---|
n | HR | 95% CI | P value | HR | 95% CI | P value | |
Age > 65 years old | 212 | 1.04 | [0.83;2.39] | 0.2 | |||
Male | 212 | 0.9 | [0.51;1.83] | 0.9 | |||
Histological cirrhosis | 212 | 2.92 | [1.06;8.07] | 0.03 | 3.35 | [1.15;9.37] | 0.02 |
Etiology of liver disease | 212 | Ref | |||||
Hepatitis B | 1.13 | [0.4;3.2] | 0.8 | ||||
Hepatitis C | 0.74 | [0.29;1.86] | 0.5 | ||||
Alcohol | 1.19 | [0.49;2.88] | 0.7 | ||||
Other | 0.33 | [0.04;2.79] | 0.31 | ||||
AFP level (ng/mL) | 205 | 1 | [0.99;1.00] | 0.5 | |||
Child–Pugh class B | 208 | 2.71 | [1.23;5.99] | 0.01 | 2.54 | [1.06;6.04] | 0.03 |
Solitary nodule | 212 | 0.58 | [0.33;1.03] | 0.06 | |||
Tumor size (cm) | 212 | 0.99 | [098;1.01] | 0.97 | |||
BCLC stage B | 212 | 2.95 | [1.3;6.54] | 0.007 | 2.6 | [1.09;6.16] | 0.03 |
Atypical pattern of tumor enhancement | 212 | 1.04 | [0.47;2.30] | 0.91 | |||
Non-smooth tumor margin | 212 | 1.77 | [1.02;3.07] | 0.04 | 1.58 | [0.86;2.88] | 0.13 |
Tumor capsule | 212 | 0.7 | [0.43;1.19] | 0.2 | |||
Abnormal vascular peritumoral enhancement | 212 | 0.49 | [0.18;1.3] | 0.17 | |||
Irregular circumferential enhancement | 0.25 | [0.03;1.8] | 0.17 | ||||
Peri-vascular location | 212 | 0.98 | [0.58;1.6] | 0.95 | |||
MTM subtype | 212 | 2.07 | [1.05;4.1] | 0.03 | 2.12 | [1.04;4.32] | 0.03 |
Edmondson grade 1 or 2 | 0.83 | [0.48;1.44] | 0.5 | ||||
Biliary marker expression | 201 | 1.78 | [0.84;3.76] | 0.13 |